These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 12794227)

  • 1. Treatment of Candida glabrata using topical amphotericin B and flucytosine.
    Shann S; Wilson J
    Sex Transm Infect; 2003 Jun; 79(3):265-6. PubMed ID: 12794227
    [No Abstract]   [Full Text] [Related]  

  • 2. Combined topical flucytosine and amphotericin B for refractory vaginal Candida glabrata infections.
    White DJ; Habib AR; Vanthuyne A; Langford S; Symonds M
    Sex Transm Infect; 2001 Jun; 77(3):212-3. PubMed ID: 11402233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and management of non-albicans vaginal candidiasis.
    Hettiarachchi N; Ashbee HR; Wilson JD
    Sex Transm Infect; 2010 Apr; 86(2):99-100. PubMed ID: 20332368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of refractory Candida krusei vaginitis with topical amphotericin B.
    Chamorro-de-Vega E; Gil-Navarro MV; Perez-Blanco JL
    Med Clin (Barc); 2016 Dec; 147(12):565-566. PubMed ID: 27567339
    [No Abstract]   [Full Text] [Related]  

  • 5. A case series of the management of symptomatic azole-resistant candida.
    Challenor R; Pinsent S; Ekanayaka R
    Int J STD AIDS; 2012 May; 23(5):375-6. PubMed ID: 22648899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of vaginitis caused by Candida glabrata: use of topical boric acid and flucytosine.
    Sobel JD; Chaim W; Nagappan V; Leaman D
    Am J Obstet Gynecol; 2003 Nov; 189(5):1297-300. PubMed ID: 14634557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of fungal peritonitis with a combination of intravenous amphotericin B and oral flucytosine, and delayed catheter replacement in continuous ambulatory peritoneal dialysis.
    Wong PN; Lo KY; Tong GM; Chan SF; Lo MW; Mak SK; Wong AK
    Perit Dial Int; 2008; 28(2):155-62. PubMed ID: 18332451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of non-albicans Candida vaginitis with amphotericin B vaginal suppositories.
    Phillips AJ
    Am J Obstet Gynecol; 2005 Jun; 192(6):2009-12; discussion 2012-3. PubMed ID: 15970877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Refractory urinary tract and vulvovaginal infection caused by Candida krusei.
    Sivasubramanian G; Sobel JD
    Int Urogynecol J Pelvic Floor Dysfunct; 2009 Nov; 20(11):1379-81. PubMed ID: 19834757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro interactions of anidulafungin with azole antifungals, amphotericin B and 5-fluorocytosine against Candida species.
    Karlowsky JA; Hoban DJ; Zhanel GG; Goldstein BP
    Int J Antimicrob Agents; 2006 Feb; 27(2):174-7. PubMed ID: 16414247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antifungal drugs in current use: a review.
    Clayton YM
    Proc R Soc Med; 1977; 70 Suppl 4(Suppl 4):15-8. PubMed ID: 122688
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy of antifungal agents in the cornea. II. Influence of corticosteroids.
    O'Day DM; Ray WA; Robinson R; Head WS
    Invest Ophthalmol Vis Sci; 1984 Mar; 25(3):331-5. PubMed ID: 6321389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Candida arthritis with flucytosine and amphotericin B.
    Weisse ME; Person DA; Berkenbaugh JT
    J Perinatol; 1993; 13(5):402-4. PubMed ID: 8263628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
    Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
    Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of amphotericin B, flucytosine and itraconazole with amphotericin B and flucytosine in the treatment of cryptococcal meningitis in AIDS.
    Chotmongkol V; Sukeepaisarncharoen W; Thavornpitak Y
    J Med Assoc Thai; 1997 Jul; 80(7):416-25. PubMed ID: 9277070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of the dosage of flucytosine in combination with amphotericin B for disseminated candidiasis: a pharmacodynamic rationale for reduced dosing.
    Hope WW; Warn PA; Sharp A; Reed P; Keevil B; Louie A; Walsh TJ; Denning DW; Drusano GL
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3760-2. PubMed ID: 17682101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triple therapy versus amphotericin B plus flucytosine for the treatment of non-HIV- and non-transplant-associated cryptococcal meningitis: retrospective cohort study.
    Xu L; Liu J; Zhang Q; Li M; Liao J; Kuang W; Zhu C; Yi H; Peng F
    Neurol Res; 2018 May; 40(5):398-404. PubMed ID: 29560802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surface response modeling to examine the combination of amphotericin B deoxycholate and 5-fluorocytosine for treatment of invasive candidiasis.
    Hope WW; Warn PA; Sharp A; Reed P; Keevil B; Louie A; Denning DW; Drusano GL
    J Infect Dis; 2005 Aug; 192(4):673-80. PubMed ID: 16028137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Candida lung abscess: successful treatment with amphotericin B and 5-flucytosine.
    Schiffman RL; Johnson TS; Weinberger SE; Weiss ST; Schwartz A
    Am Rev Respir Dis; 1982 Jun; 125(6):766-8. PubMed ID: 7091886
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of single-drug and combination antifungal therapy in an experimental model of candidiasis in rabbits with prolonged neutropenia.
    Thaler M; Bacher J; O'Leary T; Pizzo PA
    J Infect Dis; 1988 Jul; 158(1):80-8. PubMed ID: 3392423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.